Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2008
08/20/2008CN101244244A Depression treating medicine composition and preparation method thereof
08/20/2008CN101244231A Chinese medicine fragrant composition, its preparation and application
08/20/2008CN101244221A Composition for external application and preparation method
08/20/2008CN101244208A Method of preparing traditional Chinese medicine preparation for treating melancholia and anxiety neurosis
08/20/2008CN101244197A Medicament for treating chronic migraine and general headache
08/20/2008CN101244195A Medicament for treating aypnia
08/20/2008CN101244169A Chinese medicine liqueur for treating difficult and complicated disease
08/20/2008CN101244160A New anti-stress and tidepressant purpose of banana tegument extract
08/20/2008CN101244154A Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis
08/20/2008CN101244127A Medicament for treating vascular dementia
08/20/2008CN101244104A Method for increasing rare saponin content in panax ginseng total saponin extract
08/20/2008CN101244087A Sheep insect powder for treating epilepsy
08/20/2008CN101244084A Sobering-up agent of pearl oyster meat and preparation thereof
08/20/2008CN101244080A Pharmaceutical combination for preventing birth defect and improving anamnesis
08/20/2008CN101244074A Uses of epimedium brevicornum flavone and its active ingredient in preparing medicaments for accelerating neurocyte proliferation and differentiation function
08/20/2008CN101244073A Panoxatriol saponin and caffeinum pharmaceutical combination, and uses thereof
08/20/2008CN101244066A New purpose of total steroidal saponin extract
08/20/2008CN101244026A Huperzine and its derivant or its salt implantation agent, its preparation method and application
08/20/2008CN101243851A Nourishing kudzu root trunk (kudzu betel nut) formula and preparing process
08/20/2008CN101243819A Method for preparing Jupu tea
08/20/2008CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
08/20/2008CN100411687C Adhesive patch
08/20/2008CN100411686C Visual function improving agents
08/20/2008CN100411656C Application of cocoa ted extract in preparation of anti arteriosclerosis, antiageing medicine food and cosmetics
08/20/2008CN100411655C Composition comprising panax ginseng and paullinia cupana extracts
08/20/2008CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
08/20/2008CN100411618C Use of compounds that are effective as selective opiate receptor modulators
08/20/2008CN100411611C Matrix for sustained, invariant and independent release of active compounds
08/20/2008CN100411610C Liposome able to transmit blood and brain screen, medicinal compositions using hiposome as carrier and its preparation method
08/19/2008US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping
08/19/2008US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
08/19/2008US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants
08/19/2008US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
08/19/2008US7414065 Methods to modulate conditions mediated by the CXCR4 receptor
08/19/2008US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
08/19/2008US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides
08/19/2008US7414034 Administering antibody polynucleotide; controlling glutamate receptors
08/19/2008US7413884 Using antibodies as hydrolysis catalysts; reducing concentration of amyloid plaque
08/19/2008US7413747 Transdermal therapeutic system for treating Parkinsonism
08/19/2008CA2501543C Enhancement of alcohol metabolism
08/19/2008CA2488422C Stable solid medicinal ramosetron composition for oral administration
08/19/2008CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/19/2008CA2432799C Pyrazole compounds useful as protein kinase inhibitors
08/19/2008CA2390886C Use of fumaric acid derivatives for treating mitochondrial diseases
08/19/2008CA2369448C Medicament for inhibiting nf-kb
08/19/2008CA2268399C Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/19/2008CA2241469C Tetrahydroimidazo [2,1-a] isoquinoline derivatives
08/19/2008CA2205134C A method for treating vascular headaches
08/15/2008CA2621575A1 Drug detoxification protocol using microdosing
08/14/2008WO2008098192A2 Compositions and methods for treating neuropathy
08/14/2008WO2008098151A2 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
08/14/2008WO2008097991A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
08/14/2008WO2008097897A2 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
08/14/2008WO2008097861A2 MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS
08/14/2008WO2008097664A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
08/14/2008WO2008097546A2 Compounds that inhibit cholinesterase
08/14/2008WO2008097536A2 Compositions and methods for treating psychiatric diseases and disorders
08/14/2008WO2008097503A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation
08/14/2008WO2008096870A1 Aza-bridged-ring compound
08/14/2008WO2008096829A1 Tricyclic compounds
08/14/2008WO2008096791A1 Acylguanidine derivative
08/14/2008WO2008096775A1 Therapeutic agent for pain disease
08/14/2008WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives
08/14/2008WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof
08/14/2008WO2008096690A1 Polyethylene glycol derivative
08/14/2008WO2008096359A2 Agents for the treatment of multiple sclerosis and methods of using same
08/14/2008WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors
08/14/2008WO2008096046A1 Noroxymorphone for use as a medicament
08/14/2008WO2008096028A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof
08/14/2008WO2008095943A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
08/14/2008WO2008095835A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
08/14/2008WO2008095773A1 Use of flibanserin for the treatment of insomnia
08/14/2008WO2008095689A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof
08/14/2008WO2008095297A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission
08/14/2008WO2008095275A1 Methods for the treatment of senile dementia of the alzheimer's type
08/14/2008WO2008095253A1 Treatment of adhd
08/14/2008WO2008095221A1 Treatment of adhd
08/14/2008WO2008076810A3 Azabicyclic heterocycles as cannabinoid receptor modulators
08/14/2008WO2008073350A3 Acetylene derivatives and their use for binding and imaging amyloid plaques
08/14/2008WO2008071870A3 Use of agomelatine in order to obtain drugs intended for the treatment of smith-magenis syndrome
08/14/2008WO2008071869A3 Use of agomelatine in order to obtain drugs intended for the treatment of periventricular leukomalacia
08/14/2008WO2008071755A3 Casein-derived peptides having anxiolytic activity
08/14/2008WO2008067390A9 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
08/14/2008WO2008044054A3 Hydroxy-substituted benzoic acid amide compounds for use in therapy
08/14/2008WO2008041140A3 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
08/14/2008WO2008033468A3 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
08/14/2008WO2008028903A3 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
08/14/2008WO2007091250A3 Enzyme replacement therapy for treating lysosomal storage diseases
08/14/2008US20080194797 Leucine-based motif and clostridial neurotoxins
08/14/2008US20080194702 Obovatol Having Anti-Anxiety Activity
08/14/2008US20080194695 Pharmaceutical Composition Containing Sibutramine Free Base and Manufacturing Method Thereof
08/14/2008US20080194687 particle obtained by granulating 1-aminomethyl-cyclohexane-acetic acid with polyethylene glycol; antiepileptic agents
08/14/2008US20080194684 administering lipid glycerides for treating neurodegenerative disease such as multiple sclerosis; increasing transforming growth factors and tumor necrosis factors
08/14/2008US20080194683 Medicament for preventing and/or treating peripheral neuropathies
08/14/2008US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease
08/14/2008US20080194667 Compositions For Treating Amyloid Associated Diseases
08/14/2008US20080194657 Thiazole Derivatives for Treating Restless Legs Syndrome
08/14/2008US20080194656 Benzotriazole Derivatives as Cannabinoid Receptor Antagonists
08/14/2008US20080194654 Using monoamine oxidase inhibitor; prevention, therapy of gastrointestinal disorders; sexual disorders; antidepressants; cognition activators; analgesics